dihydroxyphenylalanine has been researched along with Colorectal Neoplasms in 1 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oshima, G | 1 |
| Guo, N | 1 |
| He, C | 1 |
| Stack, ME | 1 |
| Poon, C | 1 |
| Uppal, A | 1 |
| Wightman, SC | 1 |
| Parekh, A | 1 |
| Skowron, KB | 1 |
| Posner, MC | 1 |
| Lin, W | 1 |
| Khodarev, NN | 1 |
| Weichselbaum, RR | 1 |
1 other study available for dihydroxyphenylalanine and Colorectal Neoplasms
| Article | Year |
|---|---|
In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases.
Topics: Animals; Antineoplastic Agents; Cholesterol; Colorectal Neoplasms; Dihydroxyphenylalanine; Disease M | 2017 |